Intravacc

Since its privatization in 2013, Intravacc has increasingly focused on collaboration with the pharmaceutical industry and NGOs. Intravacc is part of the life & biosciences platform of First Dutch. and will further open its technology to partners developing their own vaccines. Intravacc will increasingly focus on providing services for vaccines in developing countries.

Intravacc is active in the (pre-)clinical phase of in vitro research into oral medicines. As an international contract development and manufacturing organization (CDMO) with its origins and foundation in the Netherlands, Intravacc develops new and improved vaccines for the pharmaceutical industry and NGOs. Its mission is to reduce human diseases through innovative vaccine technology.

Intravacc was established in 2013 from the Dutch Vaccine Institute (NVI) and has years of experience in translational vaccinology.